Content area
Full text
In a case series, a 43-year-old man was described, who developed sexual dysfunction following concomitant treatment with venlafaxine and atomoxetine for generalised anxiety disorder (GAD) and attention-deficit/hyperactivity disorder (ADHD) [routes not stated].
The man, who was diagnosed with GAD and ADHD, started receiving treatment with venlafaxine 75mg daily. Subsequently, his anxiety symptoms reduced. However, his symptoms of inattentiveness, hyperactivity and impulsivity, persisted. Therefore, he started receiving...